Covaxin to face WHO scrutiny this week
India’s homegrown COVID-19 vaccine Covaxin is to face scrutiny from the World Health Organization (WHO) on June 23rd when a pre-submission hearing will be held. Manufacturer Bharat Biotech received the WHO’s nod for its expression of interest for emergency use listing of Covaxin, in a step commentators regard as moving the vaccine closer to securing …